Actively Recruiting
Neurostimulation for the Treatment of Post-Stroke Aphasia
Led by QVITI S.A. · Updated on 2026-02-18
64
Participants Needed
2
Research Sites
168 weeks
Total Duration
On this page
Sponsors
Q
QVITI S.A.
Lead Sponsor
I
Icahn School of Medicine at Mount Sinai
Collaborating Sponsor
AI-Summary
What this Trial Is About
The aim of the trial is to determine whether 75Hz transcranial alternating current stimulation (tACS) synchronized with therapeutic linguistic tasks is an effective form of therapy for post-stroke aphasia.
CONDITIONS
Official Title
Neurostimulation for the Treatment of Post-Stroke Aphasia
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of Broca's or mixed aphasia by a Speech Language Pathologist
- Left hemisphere brain injury from first ischemic or hemorrhagic stroke confirmed by CT/MRI
- Chronic stage of stroke with time since stroke over 6 months
- Naming Task accuracy between 10% and 60%
- Age between 18 and 80 years
- Right-handed before stroke
- Ability to provide written informed consent
- Fluent in English
You will not qualify if you...
- Severe cognitive, auditory, or visual impairment preventing cognitive and language testing
- Presence of metal implants in the skull
- Major untreated or unstable psychiatric disease
- History of epilepsy or seizures
- Use of medication that increases risk of epileptic seizures
- Presence of cardiac stimulator, pacemaker, or vagus nerve stimulator
- History of speech, language, hearing, or intellectual disability in childhood
- Pregnancy
- High intolerance to stimulation
- Occurrence of epileptic seizure during trial
- New neurological or mental symptoms during trial
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Think & Speak Lab at Shirley Ryan AbilityLab
Chicago, Illinois, United States, 60611
Actively Recruiting
2
Abilities Research Center at Mount Sinai
New York, New York, United States, 10029
Actively Recruiting
Research Team
T
Tertia Jeppson
CONTACT
A
Aidan Rogers
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here